NCT03481439

Brief Summary

The objective is therefore to create a risk score for ADEs in an orthopedic and traumatological surgery department. The study is an prospective, observational, cohort trial. A first step will consist of: (i) a collection of PIs carried out in an orthopedic and traumatological surgery department for 1 month, (ii) a score of the clinical impact of Pharmacist Interventions using the Clinical, Econnomic and organisationnal scale by method of consensus and (iii) a statistical analysis. Statistical analysis consists of (i) logistic regression modeling, (ii) performance measurement by discrimination and calibration, and internal validation by resampling. In a second step, external validation using a new sample will be performed.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
500

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2018

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 13, 2018

Completed
28 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 13, 2018

Completed
9 days until next milestone

First Submitted

Initial submission to the registry

March 22, 2018

Completed
7 days until next milestone

First Posted

Study publicly available on registry

March 29, 2018

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

June 15, 2018

Completed
Last Updated

October 15, 2018

Status Verified

March 1, 2018

Enrollment Period

28 days

First QC Date

March 22, 2018

Last Update Submit

October 10, 2018

Conditions

Keywords

PharmacistLed medication reviewOrthopaedic surgeryTraumatology

Outcome Measures

Primary Outcomes (1)

  • Major clinical impact pharmaceutical intervention

    Occurrence of a major clinical impact pharmaceutical intervention according to the CLEO scale

    1 day

Secondary Outcomes (1)

  • pharmaceutical intervention

    1 day

Study Arms (2)

Primary cohort

Primary cohort : Cohort of patient between January and February 2017

Other: Collection of a Pharmaceutical intervention

Secondary cohort

Secondary cohort : Cohort of patient between February and March 2018

Other: Collection of a Pharmaceutical intervention

Interventions

collection of pharmaceutical interventions carried out by the pharmaceutical team in the care uni in Primary and secondary cohort

Primary cohortSecondary cohort

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Adult patient hospitalized in the department of orthopaedic surgery and traumatology on university hospital of Montpellier

You may qualify if:

  • Subject aged over 18 years
  • Subject hospitalized in the department of orthopaedic surgery and traumatology on university hospital of Montpellier.

You may not qualify if:

  • Vulnerable persons according to French law (pregnant women, adults under guardianship, persons deprived of liberty)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uhmontpellier

Montpellier, 34295, France

Location

Study Officials

  • Pierre RENAUDIN, Pharm D

    University Hospital, Montpellier

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 22, 2018

First Posted

March 29, 2018

Study Start

February 13, 2018

Primary Completion

March 13, 2018

Study Completion

June 15, 2018

Last Updated

October 15, 2018

Record last verified: 2018-03

Locations